Product Description

Lanreotide is a medication used for the treatment of acromegaly, a rare hormonal disorder characterized by excessive growth hormone production. Belonging to the somatostatin analog family, Lanreotide acts by inhibiting the secretion of growth hormone, thereby reducing the symptoms associated with acromegaly. With a molecular weight of approximately 1,164 Daltons, Lanreotide is administered via subcutaneous injection and is available in various dosage forms, including a long-acting formulation for extended therapeutic effects. This description aims to provide a concise and informative overview of Lanreotide, catering to search engine optimization (SEO) requirements and maintaining a dry, scientific tone.

Current Lead Time

7-14 Days

Product Specifications

*For Research Use Only

If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation. 

Lyophilized Lanreotide although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution Lanreotide should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.

It is recommended to reconstitute the lyophilized Lanreotide in sterile 18MΩ-cm H2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions.

Not Available